Jul 21, 2025
10:1
For every share held, investors received 10. The price per share adjusted from $1215.00 to $121.50.
The split itself did not change the total investment value.
Caliway Biopharmaceuticals Co Ltd (TWSE:6919) operates in the Biotechnology industry.
Caliway Biopharmaceuticals Co Ltd company overviewCaliway Biopharmaceuticals Co Ltd's most recent stock split was on July 21, 2025. It was a 10-for-1 forward split, so shareholders received 10 shares for every share they held.
Caliway Biopharmaceuticals Co Ltd (TWSE:6919) has split its stock 2 times: a 2-for-1 split on March 21, 2024 and a 10-for-1 split on July 21, 2025.
Caliway Biopharmaceuticals Co Ltd has split its stock 2 times. This history records 2 forward splits between March 21, 2024 and July 21, 2025.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Caliway Biopharmaceuticals Co Ltd's 10-for-1 split on July 21, 2025, every share became 10 shares.
Caliway Biopharmaceuticals Co Ltd has not announced a new split in our records. Its most recent split was on July 21, 2025, 1 year ago. Companies announce splits in advance, and any new TWSE:6919 split will appear on this page.
Already premium?